Italy
Case Report
Hypofractionated Stereotactic Radiotherapy for Orbital Metastases: A Case
Report and Review of Literature
Author(s): Blerina Resuli, Roberto Lisi, Francesca De Felice, Daniela Musio and Vincenzo TomboliniBlerina Resuli, Roberto Lisi, Francesca De Felice, Daniela Musio and Vincenzo Tombolini
Objective: To evaluate the efficacy and clinical outcome of hypofractionated stereotactic radiotherapy (HSRT) in non-small-cell lung cancer (NSCLC) cancer patients with orbital metastasis.
Case report: A 61-year-old man was admitted to the hospital referring right ptosis and dry hacking cough. HSRT was performed for the orbital metastasis followed by chemotherapy with cisplatin (60 mg/m2) and pemetrexed (500 mg/m2) on day 1 every 21 days for 4 cycles and maintenance pemetrexed (500 mg/m2) on day 1 every 21 days. Control TC scan revealed a complete response of the orbital mass.
Conclusion: HSRT should be considered a valid therapeutic alternative in the management of selected patient with orbital metastases... Read More»
DOI:
10.4172/2157-7099.1000273
Journal of Cytology & Histology received 2476 citations as per Google Scholar report